MVRx's Unattributed Round

MVRx raised a round of funding on December 08, 2009.

MVRx advances interventional therapies for heart failure through mitral valve repair. The ARTO System, the company's initial platform, targets mitral valve regurgitation associated with congestive hea…

Articles about MVRx's Unattributed Round: